(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202312 | 202212 | % Var | 202312 | 202212 | % Var | 202303 | 202203 | % Var | |
| Sales | 5728.04 | 5407.31 | 5.93 | 17466.17 | 15399.00 | 13.42 | 21612.20 | 21232.14 | 1.79 |
| Other Income | 16.91 | 66.08 | -74.41 | 89.11 | 261.21 | -65.89 | 289.57 | 147.04 | 96.93 |
| PBIDT | 1742.47 | 1520.64 | 14.59 | 5417.12 | 4619.84 | 17.26 | 6712.50 | 6307.64 | 6.42 |
| Interest | 3.87 | 1.60 | 141.87 | 11.82 | 4.28 | 176.17 | 5.47 | 279.62 | -98.04 |
| PBDT | 1738.60 | 1519.04 | 14.45 | 5405.30 | 4615.56 | 17.11 | 6707.03 | 6028.02 | 11.26 |
| Depreciation | 131.77 | 107.63 | 22.43 | 389.18 | 305.77 | 27.28 | 420.94 | 378.77 | 11.13 |
| PBT | 1606.83 | 1411.41 | 13.85 | 5016.12 | 4309.79 | 16.39 | 6286.09 | 5649.25 | 11.27 |
| TAX | 419.18 | 361.48 | 15.96 | 1286.60 | 1103.75 | 16.57 | 1616.48 | 1462.01 | 10.57 |
| Deferred Tax | 30.57 | 29.70 | 2.93 | 75.00 | 70.75 | 6.01 | 110.37 | 85.74 | 28.73 |
| PAT | 1187.65 | 1049.93 | 13.12 | 3729.52 | 3206.04 | 16.33 | 4669.61 | 4187.24 | 11.52 |
| Equity | 245.05 | 245.05 | 0.00 | 245.05 | 245.05 | 0.00 | 245.05 | 245.05 | 0.00 |
| PBIDTM(%) | 30.42 | 28.12 | 8.17 | 31.01 | 30.00 | 3.38 | 31.06 | 29.71 | 4.55 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1904.65 |
| Dr. Reddys Labs. | 1374.55 |
| Cipla | 1458.45 |
| Zydus Lifesciences | 1141.00 |
| Lupin | 2476.10 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: